All Releases
 |
Sigma-Aldrich Declares Quarterly Dividend
May 2, 2012
|
7.4 KB |
|
| |
ST. LOUIS, May 2, 2012 /PRNewswire/ -- At a Board of Directors meeting held May 1, 2012, the Directors declared a quarterly cash dividend of $.20 per share. The dividend is payable on June 15, 2012 to shareholders of record on June 1, 2012.
About Sigma-Aldrich: Sigma-Aldrich (Nasdaq:SIAL) is a leading Life Science and High Technology com...
|
|
Sigma® Life Science Introduces Kit for Integrating Transgenes into the Rosa26 Rat Locus
Apr 26, 2012
|
11.8 KB |
|
| |
ST. LOUIS, April 26, 2012 /PRNewswire/ -- Sigma-Aldrich® Corporation (Nasdaq: SIAL) today announced that Sigma Life Science, its innovative biological products and services research business, launched the first kit to precisely and efficiently integrate transgenes into the rat genome. The highly affordable CompoZr® Targeted Integration Ki...
|
|
Sigma-Aldrich Corporation To Present At Upcoming Investor Conferences
Apr 25, 2012
|
8.4 KB |
|
| |
ST. LOUIS, April 25, 2012 /PRNewswire/ -- Sigma-Aldrich Corporation (NASDAQ: SIAL) will be presenting at the following investor conferences in May:
Deutsche Bank 37th Annual Health Care Conference on Monday, May 7, 2012, at the InterContinental Boston, Boston, MA, presenting at 1:30 PM ET.
Baird's 2012 Growth Stock Conference on Tues...
|
|
Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
Apr 24, 2012
|
35.0 KB |
|
| |
ST. LOUIS, April 24, 2012 /PRNewswire/ --
HIGHLIGHTS:
2012 Results (all percentages are to comparable periods in 2011)
Q1 2012 reported sales increased 5% to $665 million, a new quarterly high. Q1 sales grew organically by 3% with Research and Fine Chemicals ("SAFC") organic sales growth of 4% and 1%, respectively. Ac...
|
|
SAGE® Labs Creates the First Tissue-Specific Gene Deletion in Rats
Apr 19, 2012
|
12.6 KB |
|
| |
ST. LOUIS, April 19, 2012 /PRNewswire/ -- Sigma-Aldrich® Corporation (Nasdaq: SIAL) today announced that Sigma Advanced Genetic Engineering (SAGE) Labs, an initiative of Sigma® Life Science, extended CompoZr® Zinc Finger Nuclease (ZFN) technology to achieve the first tissue-specific conditional knockout of an endogenous gene in rats....
|
|
Sigma-Aldrich Corporation Announces Q1-2012 Conference Call
Apr 12, 2012
|
9.0 KB |
|
| |
ST. LOUIS, Mo., April 12, 2012 (GLOBE NEWSWIRE) -- Sigma-Aldrich Corporation will hold its quarterly conference call to discuss first quarter results on Tuesday, April 24, 2012 at 11:00 AM Eastern Time.
Date:
April 24, 2012
Time:
11:00 AM ET
List...
|
|
SAFC Launches CHOZN® Platform System to Accelerate Recombinant Protein Drug Development
Apr 11, 2012
|
14.5 KB |
|
| |
ST. LOUIS, April 11, 2012 /PRNewswire/ -- Sigma-Aldrich Corporation (NASDAQ: SIAL) today announced that its custom manufacturing and services business unit, SAFC® (www.safcglobal.com), is launching the CHOZN® Platform system, a CHO (Chinese Hamster Ovary) cell expression system that allows for faster, simpler selection and scale-up of hig...
|
|
Sigma-Aldrich Acquires Research Organics to Strengthen Portfolio of PharmaGrade Raw Materials
Apr 2, 2012
|
11.6 KB |
|
| |
ST. LOUIS, April 2, 2012 /PRNewswire/ -- Sigma-Aldrich Corporation (Nasdaq: SIAL) announced today it has acquired all outstanding shares of Cleveland, Ohio-based, Research Organics, Inc., to expand the Company's buffer production capacity and to increase its portfolio of PharmaGrade raw materials for the biopharmaceutical and diagnostic markets. Re...
|
|
CRF Institute Names Sigma-Aldrich Top Employer Europe 2012
Mar 23, 2012
|
10.2 KB |
|
| |
March 23, 2012 - St. Louis, Mo. - Sigma-Aldrich® Corporation (Nasdaq: SIAL) was recently named one of Europe's Top Employers by the Corporate Research Foundation (CRF) Institute, a joint initiative of academics, business journalists, trade associations, researchers and inter...
|
|
Sigma-Aldrich Opens New Wuxi Packaging and Quality Control Facilities to Enhance Capabilities Serving China and Asia-Pacific Region
Mar 15, 2012
|
10.1 KB |
|
| |
ST. LOUIS, March 15, 2012 /PRNewswire/ -- Sigma-Aldrich® Corporation (NASDAQ: SIAL) today announced the opening of its new facility in Wuxi, China, that will provide localized packaging, analytical services and quality control for high-quality products to support the Company's research and industrial customers in the region.
"Over the l...
|
|
Sigma-Aldrich Enhances Asia-Pacific Customer Support With New Distribution and Packaging Capabilities in India
Mar 15, 2012
|
11.7 KB |
|
| |
ST. LOUIS, March 15, 2012 /PRNewswire/ -- Sigma-Aldrich Corporation (Nasdaq: SIAL) recently completed a 57,000-square-foot expansion of its Bangalore, India, campus. The expansion, which includes an expanded distribution center and new packaging facility, enhances the Company's distribution capabilities in the Asia-Pacific region, increasing operat...
|
|
Sigma-Aldrich Corporation Will Hold Its Business Review March 29, 2012
Mar 15, 2012
|
8.7 KB |
|
| |
ST. LOUIS, March 15, 2012 /PRNewswire/ -- Sigma-Aldrich Corporation (NASDAQ: SIAL), will hold its Business Review with the financial community on Thursday, March 29, 2012 at 8:30 AM Central Time and 9:30 AM Eastern Time. Presenters will include: President & CEO Rakesh Sachdev; Vice President & Treasurer Kirk Richter; EVP & President, SAFC Gilles C...
|
|
SAFC Hitech® Opens New Taiwan Facility to Enhance Global Capacity for High-Brightness LED Precursor Manufacturing
Mar 14, 2012
|
5.6 KB |
|
| |
...
|
|
Sigma-Aldrich (Nasdaq: SIAL) Announces Appointment of Jan Bertsch as Executive Vice President and CFO
Feb 23, 2012
|
8.8 KB |
|
| |
ST. LOUIS, Feb. 23, 2012 /PRNewswire/ -- Sigma-Aldrich is pleased to announce the appointment of Jan Bertsch (age 55) as Executive Vice President and Chief Financial Officer (CFO) effective March 5, 2012.
Prior to her appointment at Sigma-Aldrich, Ms. Bertsch was employed by BorgWarner, most recently as Vice President, Controller and Princip...
|
|
Sigma® Life Science Obtains Global License for Kyoto University's iPS Cell Patent Portfolio, Deepens Commitment to Drug Discovery and ADME/Toxicology
Feb 21, 2012
|
12.3 KB |
|
| |
ST. LOUIS, Mo., Feb. 21, 2012 /PRNewswire/ -- Sigma-Aldrich Corporation (Nasdaq: SIAL) today announced that Sigma Life Science, its innovative biological products and services research business, has furthered its commitment to stem cell research, drug discovery and ADME/Toxicology by acquiring a worldwide license to use Kyoto University's induced p...
|
|
Sigma-Aldrich (Nasdaq:SIAL) Declares Increased Quarterly Dividend
Feb 14, 2012
|
7.4 KB |
|
| |
ST. LOUIS, Feb. 14, 2012 /PRNewswire/ -- At a meeting held today, the Directors increased the Company's quarterly cash dividend by 11.1% to $0.20 per share. The dividend is payable on March 15, 2012 to shareholders of record on March 1, 2012.
About Sigma-Aldrich: Sigma-Aldrich is a leading Life Science and High Technology company whose b...
|
|
Sigma-Aldrich (NASDAQ: SIAL) Reports Diluted EPS of $0.89, a 17% Increase, and 5% Sales Growth for Q4 2011. Full Year 2011 Diluted EPS Increased 14%. 2012 Diluted EPS Expected to Increase to $3.90 to $4.05
Feb 9, 2012
|
38.0 KB |
|
| |
ST. LOUIS, Feb. 9, 2012 /PRNewswire/ --
HIGHLIGHTS:
2011 Results (all percentages are to comparable periods in 2010)
Q4 Results
Reported sales increased 5% to $610 million. Sales grew organically by 3% with Research and Fine Chemicals ("SAFC") sales growing organically by 1% and 7%, respectively. Acquisitions contributed 2% to sales ...
|
|
Sigma-Aldrich Completes Acquisition of BioReliance
Jan 31, 2012
|
13.1 KB |
|
| |
ST. LOUIS, Jan. 31, 2012 /PRNewswire/ -- From: Rakesh Sachdev, President and CEO:
Sigma-Aldrich Corporation (NASDAQ:SIAL), a leading Life Science and High Technology company, announced it has completed its acquisition of BioReliance Holdings, Inc., a leading provider of global biopharmaceutical testing services, from Avista Capital Par...
|
|
Sigma-Aldrich Corporation to Present at Upcoming Investor Conferences
Jan 27, 2012
|
8.5 KB |
|
| |
ST. LOUIS, Jan. 27, 2012 /PRNewswire/ -- Sigma-Aldrich Corporation (NASDAQ: SIAL) will be presenting at the following investor conferences in February:
Leerink Swann 2012 Global Healthcare Conference on Thursday, February 16, 2012, at the Waldorf Astoria Hotel, New York, NY, presenting at 9:00 A.M. (EST).
Citi 2012 Global Healthcare ...
|
|
Sigma-Aldrich Corporation Announces Q4 Conference Call
Jan 10, 2012
|
8.7 KB |
|
| |
ST. LOUIS, Jan. 10, 2012 (GLOBE NEWSWIRE) -- Sigma-Aldrich Corporation (Nasdaq:SIAL) will hold its quarterly conference call to discuss forth quarter resutls on Thursday, February 9, 2012 at 10:00 AM Central Time (11:00 AM Eastern Time).
Date: February 9, 2012
Time: 11:00 AM ET
Listen via Internet: http://investor.sigmaaldr...
|
|
|
= add release to Briefcase
